Origin
- Started as VAM Organics
- Focussed on VAM, Acetic Acid & Acetic Anhydride
Global Leader in Specialty Chemicals & CDMO
About Us
Who We Are
Jubilant Ingrevia Limited is a leading solutions provider of Specialty Chemicals & CDMO globally, serving Pharmaceutical, Nutrition, Agrochemical, Personal Care, Semiconductor and Industrial customers. We offer customised solutions that are innovative, cost-effective and conform with global quality standards, with a broad portfolio of 130+ products.
Backed by over 45 years of legacy in the chemicals industry, we are amongst the top players globally in Pyridine & Picolines, Pyridine derivatives, Acetic Anhydride, Vitamin B3 and many other products. We also have a fast-growing Custom Development and Manufacturing business (CDMO) serving pharmaceuticals, agrochemicals and semiconductor sectors.
We serve customers in the United States (US), European Union (EU), Japan, Middle East, South East Asia and other geographies, in addition to the domestic market, from our 50+ state-of-the-art plants across 6 manufacturing facilities in India with a workforce of over 2,300 employees. Our three R&D centres employ 150 scientists engaged in cutting-edge research and innovation.
Jubilant Ingrevia Limited is a Responsible Care-certified company and ranked highly in global ESG indices such as EcoVadis and Dow Jones Sustainability Index. In 2024, Jubilant Ingrevia Limited was also recognised by the World Economic Forum (WEF) and entered its prestigious Global Lighthouse Network (GLN) for deployment of 4IR technologies.
Our Purpose, Vision, and Values
Purpose
Enable a Sustainable World through Chemistry
Vision
Be a leading provider of innovative solutions in our core chemistries globally
Values
Inspire
Challenge
Innovate
Excel
Collaborate
Promise
Caring
Sharing
Growing
We will, with utmost care for the environment and society, continue to enhance value for our customers by providing innovative products and economically efficient solutions; and for our stakeholders through growth, cost effectiveness and wise investment of resources.
Journey and Legacy
Our journey spans four distinct phases of growth and expansion built over the past 45 years:
Expansion & Diversification
- Foray into Pyridine Chemistry
- Expansion of Acetyls Business
Forward Integration
- Forward integration into Pyridine derivatives
- Launch of Nutrition business (Vit B3)
Transformation into Specialty Leader
- Expansion of Pyridine derivatives
- Foray into Diketene derivatives
- Focus on CDMO (Agro, Pharma, Semi-Con)
- Specialty products in Nutrition (Cosmetic B3, Food B3, Choline Salts etc.)
Key Highlights FY 2026
₹ 4,388 Crore
Total Revenue
₹ 607 Crore
EBITDA
14%
EBITDA Margin
₹ 278 Crore
PAT
6
Manufacturing Facilities
50+
Plants
3
R&D Centres
150
Scientists
130+
Products
2,300+
Employees
30+
Active CDMO programmes across pharmaceuticals, agrochemicals, semiconductors & electronics, personal care and nutrition
100+
Pipeline opportunities in CDMO and Specialty Chemicals
₹ 3,400+ Crore
Peak revenue potential
20+
Molecules confirmed As on March 31, 2026
10+
Molecules in advanced stage
50+
Products in R&D pipeline
₹120+ Crore
Lean savings in
FY 2026